symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
AEMD,1.44,1.337711,14599,3576283,0,1.42-8.7,-0.05,"Aethlon Medical, Inc.",USD,0000882291,US00808Y3071,00808Y307,NASDAQ Capital Market,NASDAQ,Medical Devices,https://www.aethlonmedical.com,"Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.","Dr. Charles J. Fisher Jr., M.D.",Healthcare,US,15,619 941 0360,11555 Sorrento Valley Road,San Diego,CA,92121,0.815621,1.88562,https://financialmodelingprep.com/image-stock/AEMD.png,1999-03-04,False,False,True,False,False
